Abstract
Covalent intermediates between topoisomerase I and DNA can become dead-end complexes that lead to cell death. Here, the isolation of the gene for an enzyme that can hydrolyze the bond between this protein and DNA is described. Enzyme-defective mutants of yeast are hypersensitive to treatments that increase the amount of covalent complexes, indicative of enzyme involvement in repair. The gene is conserved in eukaryotes and identifies a family of enzymes that has not been previously recognized. The presence of this gene in humans may have implications for the effectiveness of topoisomerase I poisons, such as the camptothecins, in chemotherapy.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Sequence
-
Animals
-
Camptothecin / pharmacology
-
DNA Repair*
-
DNA Topoisomerases, Type I / genetics
-
DNA Topoisomerases, Type I / metabolism*
-
DNA, Fungal / metabolism*
-
Expressed Sequence Tags
-
Genes, Fungal
-
Humans
-
Molecular Sequence Data
-
Mutation
-
Phosphoric Diester Hydrolases / chemistry
-
Phosphoric Diester Hydrolases / genetics*
-
Phosphoric Diester Hydrolases / metabolism
-
Saccharomyces cerevisiae / drug effects
-
Saccharomyces cerevisiae / enzymology
-
Saccharomyces cerevisiae / genetics*
-
Sequence Alignment
Substances
-
DNA, Fungal
-
Phosphoric Diester Hydrolases
-
TDP1 protein, human
-
tyrosyl-DNA phosphodiesterase
-
DNA Topoisomerases, Type I
-
Camptothecin
Associated data
-
GENBANK/AF182002
-
GENBANK/AF182003